Table S1. Oligonucleotide Sequences of 15 multiplex PCR sets and amplification size fragments. (DOCX 17Â kb
Table S1. Sequencing parameters. Table S2. Detailed information for primers used for Sanger sequenci...
Primer sequences for PCR amplification of the exons and exon/intron junctions of EXT1 and EXT2. (DOC...
Duchenne/Becker muscular dystrophy (DMD/BMD) is an X-linked neuromuscular disease due to pathogenic ...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
NGS protocol and the list of genes in the neuromuscular disorder panel. (DOCX 20 kb
PRISMA checklist, protocol, search term, meta-analyses on outcomes other than primary, and character...
Clinical presentations and phenotypes of the 27 MYO-SEQ index cases with suspected pathogenic varian...
Selected genes with reported skeletal muscle expression which could contribute to LGMD. (DOCX 16 kb
Clinical and dystrophin immunostaining in the patients with a small mutation. Table S2. Patients wit...
Dystrophin rescue is not preferential to a particular myofiber type. IF in serial sections were stai...
5′RACE reveals the presence of a novel exon 1. (a, b) Two sequences found several times by 5′RACE PC...
Intra-sample variabilityâdystrophin protein (% relative to WT). The table provides individual valu...
Quality parameters and description of all mutations analyzed with Illumina VeraCode GoldenGate assay...
Table S1. Sequencing parameters. Table S2. Detailed information for primers used for Sanger sequenci...
Primer sequences for PCR amplification of the exons and exon/intron junctions of EXT1 and EXT2. (DOC...
Duchenne/Becker muscular dystrophy (DMD/BMD) is an X-linked neuromuscular disease due to pathogenic ...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
NGS protocol and the list of genes in the neuromuscular disorder panel. (DOCX 20 kb
PRISMA checklist, protocol, search term, meta-analyses on outcomes other than primary, and character...
Clinical presentations and phenotypes of the 27 MYO-SEQ index cases with suspected pathogenic varian...
Selected genes with reported skeletal muscle expression which could contribute to LGMD. (DOCX 16 kb
Clinical and dystrophin immunostaining in the patients with a small mutation. Table S2. Patients wit...
Dystrophin rescue is not preferential to a particular myofiber type. IF in serial sections were stai...
5′RACE reveals the presence of a novel exon 1. (a, b) Two sequences found several times by 5′RACE PC...
Intra-sample variabilityâdystrophin protein (% relative to WT). The table provides individual valu...
Quality parameters and description of all mutations analyzed with Illumina VeraCode GoldenGate assay...
Table S1. Sequencing parameters. Table S2. Detailed information for primers used for Sanger sequenci...
Primer sequences for PCR amplification of the exons and exon/intron junctions of EXT1 and EXT2. (DOC...
Duchenne/Becker muscular dystrophy (DMD/BMD) is an X-linked neuromuscular disease due to pathogenic ...